Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Policy & Legislation

Tuesday Links

Posted on January 24, 2023January 24, 2023 by John C. Goodman
  • Paragon study: In 2023, the federal government is expected to spend 6.2 percent of the economy (or more than $1.6 trillion) on mandatory health programs. The Congressional Budget Office (CBO) estimates that within 30 years, the federal government will annually spend at least 9 percent of the economy on those programs. And this is a conservative estimate.
  • A little-noticed provision of the omnibus spending bill could give the Food and Drug Administration (FDA) the power to ban off-label use of approved therapies, even though 1 in 5 prescriptions written are for an off-label use.
  • Study: Laughter really is contagious – and that’s good. (WaPo)
  • Diversity training not only doesn’t work, it may actually backfire. So why are we spending $3.4B a year on it? (NYT)
  • Fourth Quarter lobbying: almost $7 million by the American Hospital Association and $6.6 million by PhRMA. As Milton Friedman said, the question is not why we get so many bad laws; the question is, why aren’t things worse?
  • Amazon will sell generic drugs for as little as $5 a month. But, no Medicare or Medicaid or private insurance.
  • 25 of the 37 novel drugs approved in 2022, were first approved in the US.
+

The War on Drugs that Save Lives and Cure Diseases

Posted on January 24, 2023January 24, 2023 by John C. Goodman

About 85% of new medicines launched between 2012 and 2021 were available in the U.S., compared to 61% in Germany, 59% in the U.K. and 52% in France and Italy. Bluebird bio in 2021 said it was unwinding operations in Europe and withdrawing gene therapies for rare diseases, citing the challenges of “achieving appropriate value…

+

FDA to Decide Whether Covid Boosters Become an Annual Ritual Like Flu Shots

Posted on January 23, 2023 by Devon Herrick

Did you get your flu vaccine this year? How about last year? For me it’s been a few years. As I’ve written before, the Centers for Disease Control and Prevention (CDC) must decide six months in advance which strains of influenza circulating in Asia are likely to hit North America the following winter. The flu vaccine is a cocktail of four different flu strains designed to combat the strains likely to infect Americans. Sometimes the CDC guesses right, and the United States experiences a mild flu season. In other years a strain that nobody expected somehow becomes dominant and spreads throughout the US and flu is widespread.

+

Monday Links

Posted on January 23, 2023 by John C. Goodman
  • UK study: When hospitals merge, patients suffer.
  • Only about one-third of Americans think the US health care system has minor or no problems–and that percentage hasn’t varied much in the last 20 years. And that includes the passage and enactment of Obamacare.
  • UK ambulances took an average of 1 hour & 32 minutes to respond to heart attacks & strokes last month.  5 X higher than target, double the average in November.
  • Study: Even a little alcohol can be harmful to your health.
  • A lot of health provisions were stuck in the omnibus spending bill. (NYT)
+
  • Previous
  • 1
  • …
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • …
  • 232
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 36 other subscribers

Popular Topics

©2025 The Goodman Institute Health Blog | Website by Lexicom